Candin for the Treatment of Common Warts
Public ClinicalTrials.gov record NCT05889845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Candin for the Treatment of Common Warts (Verruca Vulgaris) in Adolescents and Adults
Study identification
- NCT ID
- NCT05889845
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Nielsen BioSciences, Inc.
- Industry
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Interventions
- Candin, Intradermal Solution Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2025
- Primary completion
- Aug 26, 2025
- Completion
- Aug 26, 2025
- Last update posted
- Sep 4, 2025
2025
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology | Birmingham | Alabama | 35244 | — |
| Arkansas Pediatric Clinic | Bryant | Arkansas | 72022 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Dermatology Clinic of Arkansas | Hot Springs | Arkansas | 71913 | — |
| Velocity Clinical La Mesa | La Mesa | California | 91942 | — |
| Long Beach Research | Long Beach | California | 90805 | — |
| Integrative Skin Research | Sacramento | California | 95815 | — |
| Velocity Clinical Englewood | Englewood | Colorado | 80110 | — |
| Kaminska Dermatology | Chicago | Illinois | 60657 | — |
| Integrated Dermatology of Newton-Brighton | Brighton | Massachusetts | 02135 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Schlessinger MD | Omaha | Nebraska | 68144 | — |
| Advocare Berlin Medical Associates | Berlin | New Jersey | 08009 | — |
| Bryn Mawr Health Center | Newtown Square | Pennsylvania | 19073 | — |
| Velocity Clinical Spartanburg | Spartanburg | South Carolina | 29303 | — |
| DermResearch | Austin | Texas | 78759 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Velocity Clinical Hampton | Hampton | Virginia | 23666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05889845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05889845 live on ClinicalTrials.gov.